Kumar, A., Casulo, C., Advani, R., Budde, E., Barr, P., Batlevi, C., Chen, R., Constine, L., Courtien, A., Dandapani, S., Drullinsky, P., Friedberg, J., Hamlin, P., Hoppe, R., Matasar, M., McArthur, G., Miller, S., Moskowitz, A., Noy, A., Schoder, H., Straus, D., Yang, J., Younes, A., Zelenetz, A., Yahalom, J., & Moskowitz, C. (n.d.). a PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA. Hematological oncology, 35, 171–172. http://access.bl.uk/ark:/81055/vdc_100047339759.0x00001a